Ad
related to: symptoms after chemo treatments for women over 70 1/2 percent of death
Search results
Results From The WOW.Com Content Network
Cancer and nausea are associated in about fifty percent of people affected by cancer. [1] This may be as a result of the cancer itself, or as an effect of the treatment such as chemotherapy, radiation therapy, or other medication such as opiates used for pain relief. About 70–80% of people undergoing chemotherapy experience nausea or vomiting.
Pain and sensory abnormalities can persist for months or years after treatment completion. Some patients may experience “coasting,” where symptoms intensify after completion of treatment. [3] As such, patients can be cancer-free and still suffer from disabling neuropathy induced by cancer treatment. [3]
The symptoms of PCCI were recognized by researchers in the 1980s, who typically described it as mild cognitive impairment subsequent to successful cancer treatment. [4] Some authors say that it was identified primarily in breast cancer survivor and support groups as affecting a subset of individuals treated with chemotherapy , who attributed it ...
The newest 5-HT 3 inhibitor, palonosetron (Aloxi), also prevents delayed nausea and vomiting, which can occur during the 2–5 days after treatment. Since some patients have trouble swallowing pills, these drugs are often available by injection , as orally disintegrating tablets , or as transdermal patches .
Constitutional Symptoms. Unexplained weight loss: Weight loss that is unintended and not explained by diet, exercise or other illness may be a warning sign of many types of cancer; Unexplained pain: Pain that persists, has no clear cause, and does not respond to treatment may be a warning sign of many types of cancers.
Research suggests that 70 percent of people with bipolar disorder experience their first manic episode between 15 and 24 years old, though it can happen later in life.
All ages, most frequently ~65–75 years old [2] Risk factors: Smoking, previous chemotherapy or radiation therapy, myelodysplastic syndrome, benzene [1] Diagnostic method: Bone marrow aspiration, blood test [3] Treatment: Chemotherapy, radiation therapy, stem cell transplant [1] [3] Prognosis: Five-year survival ~29% (US, 2017) [2] Frequency ...
About 70% of women with advanced disease respond to initial treatment, most of whom attain complete remission, but half of these women experience a recurrence 1–4 years after treatment. [26] Brain metastasis is more common in stage III/IV cancer but can still occur in cancers staged at I/II.